Study shows coupons lead to big profits for drugmakers

NPR's Marketplace reported this morning:

In the last few years, there's been such a spike in drug coupons, pharmaceutical companies have barely been able to print them fast enough.

Coupons help patients shoulder the cost of expensive prescriptions, but a new paper out in the New England Journal of Medicine finds certain coupons are also a windfall for drug companies. Harvard Business School economist Leemore Dafny, Northwestern’s Chris Ody and UCLA’s Matt Schmitt found when manufacturers issued coupons right before a generic competitor entered the market, branded drug sales soared by 60 percent.

The full NPR story is here.

Leave a Reply

Your email address will not be published. Required fields are marked *